Status:
COMPLETED
Plasma Myeloperoxidase Levels in Patients With Coronary Artery Disease
Lead Sponsor:
Isfahan University of Medical Sciences
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
35-70 years
Brief Summary
The investigators sought to assess whether plasma myeloperoxidase (MPO) levels differ among patients with stable and unstable CAD patients and control subjects, and correlate with inflammatory and cli...
Detailed Description
Elevation of the leukocyte enzyme myeloperoxidase (MPO) in stable coronary artery disease (CAD) patients in contrast to unstable CAD patients is controversial and its relationship with some inflammato...
Eligibility Criteria
Inclusion
- Stable and unstable patients with angiographically documented coronary artery disease.
- Control subjects without angiographically documented coronary artery disease.
- All subjects
Exclusion
- Patients with recent (with in 6 month) myocardial infarction or cardiovascular events,
- surgery (with in 3 month),
- cancer and
- infective or inflammatory diseases were not included in the study.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01239979
Start Date
January 1 2009
End Date
November 1 2010
Last Update
December 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isfahan Cardiovascular Research Center
Isfahan, Isfahan, Iran, 81465-1148